Ilumina (ILMN) Forms New Company for Gene Based Cancer Test
November 29, 2015 at 19:00 PM EST
Shares of Ilumina Inc. (ILMN) were up +10.82 or +6.55 percent to $175.99 in Monday's premarket after the company announced it was forming a new company to develop a simple blood test for the early screening of cancer in people that did not show symptoms. Ilumina stock closed at $165.17 per share, down -2.55 or ... READ MORE Read the rest of Ilumina (ILMN) Forms New Company for Gene Based Cancer Test at InvestorGuide.com .
